CCP
HGEN

Corient Capital Partners’s HUMANIGEN, INC. HGEN Stock Holding History

Corient Capital Partners’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$19K Hold
10,461
– – ﹤0.01% 670
2022
Q2 		$19K Buy
+10,461
New +$23.5K ﹤0.01% 685

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Corient Capital Partners's HGEN Position: Q3 2022 in Review

Corient Capital Partners held its HUMANIGEN, INC. (HGEN) position steady in Q3 2022 at 10,461 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Corient Capital Partners first reported a position in HGEN in Q2 2022 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Corient Capital Partners held 10,461 shares of HUMANIGEN, INC. worth $19K as of Q3 2022.
  • Corient Capital Partners left its HUMANIGEN, INC. share count unchanged in Q3 2022.
  • HUMANIGEN, INC. made up ﹤0.01% of Corient Capital Partners's portfolio in Q3 2022, its #670 holding.
  • Corient Capital Partners first reported a position in HUMANIGEN, INC. in Q2 2022 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.